Form D · Other Technology
X1 Biotech Inc.
Needham, MA · CIK 0002068848
Offering snapshot reported Jun 15, 2026 · SEC filing
- Reported sold
- $40K Offering amount: $2M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 20, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 15, 2026 | Initial | $40,000 | No comparison | 2 | SEC filing |
| Dec 11, 2025 | Amendment | $95,000 | $0vs May 21, 2025 | 5 | SEC filing |
| May 21, 2025 | Initial | $100,000 | No comparison | 1 | SEC filing |
| May 21, 2025 | Initial | $95,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-587359
Source: Form D, filed Jun 15, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Aceti | Executive |
| Joseph Arboleda Valasquez | Director |
| Joseph Arboleda Velasquez | Director |
| Neal Chen | Director |
| Dean Eliott | Director |
| Lawrence Kaufman | Executive |
| Leo Kim | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
935 Great Plain Avenue #140
Needham, MA, 02492
Needham, MA, 02492